| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/16/2000 | CN1244796A Pellets having a core coated with an antifungal and a polymer |
| 02/16/2000 | CN1244795A Method of manufacturing porous matrix-type controlled release systems using emulsion technique |
| 02/16/2000 | CN1244429A Hedgelog protein medicinal composition and its use |
| 02/16/2000 | CN1244389A Elemi olefine injecta and its preparation |
| 02/16/2000 | CN1049358C Eye drops containing vinyl carboxylate polymer and its producing method |
| 02/16/2000 | CN1049356C Protein-containing aqueous solutions |
| 02/16/2000 | CN1049333C Process for producing fine particulate materials |
| 02/15/2000 | US6025510 Process for stabilizing and dispersing vegetable oils which contain polyunsaturated fatty acid radicals by means of γ-cyclodextrin |
| 02/15/2000 | US6025482 Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling |
| 02/15/2000 | US6025477 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 02/15/2000 | US6025475 Antibody |
| 02/15/2000 | US6025446 Wound healing agent with sensitivity; equilibrium controlled diffusion |
| 02/15/2000 | US6025396 Stable prostaglandin E1-containing injectable composition |
| 02/15/2000 | US6025389 A mineral oil, one or more fatty alcohols or fatty esters, a polyoxyethylene ether or ester surfactant, xanthan gum, water and a method for treating a bacterial infection using said composition. |
| 02/15/2000 | US6025357 Anthelmintic paste |
| 02/15/2000 | US6025340 Surface expression of enzyme in gene directed prodrug therapy |
| 02/15/2000 | US6025337 Solid microparticles for gene delivery |
| 02/15/2000 | US6025325 Pegylated obese (ob) protein compositions |
| 02/15/2000 | US6025324 Pegylated obese (ob) protein compositions |
| 02/15/2000 | US6025140 Membrane-permeable constructs for transport across a lipid membrane |
| 02/15/2000 | US6024987 Pharmaceutical, orally applicable composition |
| 02/15/2000 | US6024980 Multiphase soft gelatin dosage form |
| 02/15/2000 | US6024978 Oral drug composition with lipophilic compounds |
| 02/15/2000 | US6024977 Covalent polar lipid conjugates with neurologically active compounds for targeting |
| 02/15/2000 | US6024976 Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| 02/15/2000 | US6024974 Transdermal drug delivery |
| 02/15/2000 | US6024963 Potentiation of immunogenic response |
| 02/15/2000 | US6024959 Pharmaceutical composition containing pectin and a phospholipid used as an antidiarrheal and antiulcer agent |
| 02/15/2000 | US6024957 Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same |
| 02/15/2000 | US6024941 Vitamin a and stabilizers |
| 02/15/2000 | CA2093667C Mouse monoclonal antibodies and uses thereof |
| 02/15/2000 | CA2005300C Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus |
| 02/11/2000 | CA2280241A1 Method of producing iron-whey-proteolysate complex |
| 02/10/2000 | WO2000006759A2 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same |
| 02/10/2000 | WO2000006659A1 Pressure-sensitive adhesive composition and moisture-permeable pressure-sensitive adhesive tape, pressure-sensitive adhesive drug composition, and pressure-sensitive adhesive tape preparation each containing the composition |
| 02/10/2000 | WO2000006609A1 Carrageenan compositions, and processes for their production |
| 02/10/2000 | WO2000006579A2 Pyrrolo[2,1-b][1,3]benzothiazepines with atypical antipsychotic activity |
| 02/10/2000 | WO2000006534A1 Compounds and compositions for delivering active agents |
| 02/10/2000 | WO2000006244A2 Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy |
| 02/10/2000 | WO2000006243A2 Absorbable brachytherapy and chemotherapy delivery devices and methods |
| 02/10/2000 | WO2000006202A1 Virucide drug containing iodine |
| 02/10/2000 | WO2000006195A1 Targeting pharmaceutical agents to injured tissues |
| 02/10/2000 | WO2000006194A2 Depletion of cells responsible for antibody-mediated graft rejection |
| 02/10/2000 | WO2000006188A1 Hair growth/maintenance compositions and methods involving the same |
| 02/10/2000 | WO2000006184A1 Pulmonary delivery of active agents |
| 02/10/2000 | WO2000006179A1 Cryogranulation of activated protein c |
| 02/10/2000 | WO2000006161A1 Prevention of migraine recurrence |
| 02/10/2000 | WO2000006155A1 Stabilized ascorbic acid, composition, and method of use |
| 02/10/2000 | WO2000006152A1 Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin |
| 02/10/2000 | WO2000006142A1 Injectable propofol formulations |
| 02/10/2000 | WO2000006130A1 Estradiol-containing patch for transdermal administration of hormones |
| 02/10/2000 | WO2000006126A1 Rapidly disintegrable solid preparation |
| 02/10/2000 | WO2000006124A2 A novel excipient for the lyophilization of aqueous suspensions of microparticles |
| 02/10/2000 | WO2000006123A1 Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
| 02/10/2000 | WO2000006121A1 Medicinal aerosol formulations |
| 02/10/2000 | WO2000006120A1 Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier |
| 02/10/2000 | WO2000006119A1 New injectable formulations containing ramoplanin |
| 02/10/2000 | WO2000006117A1 A moldable solid delivery system |
| 02/10/2000 | WO2000006114A1 Topical moisture regulating compositions |
| 02/10/2000 | WO2000006108A1 Casein formulations for the delivery of bioactive constituents |
| 02/10/2000 | WO2000005974A1 Novel chitosan-containing liquid compositions and methods for their preparation and use |
| 02/10/2000 | WO1999065936A3 Composition for the treatement of immune deficiencies and methods for its preparation and use |
| 02/10/2000 | WO1999064073A3 Recombinant immunotoxin directed against the hiv-1 gp120 envelope glycoprotein |
| 02/10/2000 | WO1999063971B1 Micro-osmotic controlled drug delivery systems |
| 02/10/2000 | WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors |
| 02/10/2000 | WO1999063939A3 Multibinding inhibitors of cyclooxygenase-2 |
| 02/10/2000 | WO1999062526A3 Use of genetically engineered antibodies to cd38 to treat multiple myeloma |
| 02/10/2000 | WO1999060948A3 Medium for treating eye diseases |
| 02/10/2000 | WO1999053908A3 Pro-drug conjugates for the treatment of stroke and other ischaemic conditions |
| 02/10/2000 | WO1999045126A3 Enhanced prodrug activation |
| 02/10/2000 | WO1999036105A3 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE |
| 02/10/2000 | DE19835611A1 Neuartige Phospholipide mit synthetischen, ungesättigten Alkyl- und Acylketten Novel synthetic phospholipids with unsaturated alkyl and acyl chains |
| 02/10/2000 | DE19835346A1 Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren Two-piece capsule for holding pharmaceutical preparations for powder inhalers |
| 02/10/2000 | CA2581111A1 Rapidly disintegrable solid preparation |
| 02/10/2000 | CA2525555A1 Rapidly disintegrable solid preparation |
| 02/10/2000 | CA2362338A1 Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin |
| 02/10/2000 | CA2339125A1 Novel chitosan-containing liquid compositions and methods for their preparation and use |
| 02/10/2000 | CA2338987A1 Adhesive agent composition, and permeable adhesive tape, adhesive drug composition and adhesive tape preparation containing the adhesive agent composition |
| 02/10/2000 | CA2338861A1 Estradiol-containing patch for transdermal administration of hormones |
| 02/10/2000 | CA2338797A1 Hair growth/maintenance compositions and methods involving the same |
| 02/10/2000 | CA2338779A1 Casein formulations for the delivery of bioactive constituents |
| 02/10/2000 | CA2338766A1 Cryogranulation of activated protein c |
| 02/10/2000 | CA2337496A1 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same |
| 02/10/2000 | CA2332526A1 New injectable formulations containing ramoplanin |
| 02/10/2000 | CA2307760A1 Stabilized ascorbic acid, composition, and method of use |
| 02/09/2000 | EP0978289A1 Virucide drug containing iodine |
| 02/09/2000 | EP0978288A1 Medicinal composition |
| 02/09/2000 | EP0978285A1 Pharmaceutical composition of hedgehog proteins and use thereof. |
| 02/09/2000 | EP0978282A2 Sublingual composition containing apomorphine for diagnosing functional impotence |
| 02/09/2000 | EP0978276A2 Polymer coated tablet comprising amoxycillin and clavunalate |
| 02/09/2000 | EP0977732A1 Amphiphilic compounds with at least two hydrophilic and at least two hydrophobic groups on a di- oligo- or polyene base |
| 02/09/2000 | EP0977725A1 New fatty acid derivatives |
| 02/09/2000 | EP0977626A1 Composition based on alkylpolyglycosides and fatty alcohols, and uses thereof |
| 02/09/2000 | EP0977600A2 Contrast agents |
| 02/09/2000 | EP0977588A2 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines |
| 02/09/2000 | EP0977565A1 Pharmaceutical composition |
| 02/09/2000 | EP0977562A1 Methods and compositions for delivery of taxanes |
| 02/09/2000 | EP0977557A1 Pellet-type formulation intended for treating the intestinal tract |
| 02/09/2000 | EP0977554A1 Confectionery compositions |
| 02/09/2000 | EP0977553A1 Throat soothing compositions |